Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 3, 2012, Pages 377-384

  Nusca, Annunziata ^a   Patti, Giuseppe ^a   Marino, Francesco ^a   Mangiacapra, Fabio ^a   D'Ambrosio, Andrea ^a   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

glucose levels; percutaneous coronary intervention; peri procedural myocardial infarction; restenosis

Indexed keywords

GLUCOSE;

AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEOINTIMA; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865656834     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23185     Document Type: Article

References (36)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234. (Pubitemid 28350165)
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D,. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444. (Pubitemid 23046633)
3. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW,. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-1825. (Pubitemid 26349292)
4. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schömig A,. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866-1873. (Pubitemid 29010448)
5. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB,. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589. (Pubitemid 28435240)
6. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM,; CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 2008; 101: 303-307. (Pubitemid 351162961)
7. Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM,; TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 46: 178-180. (Pubitemid 40905149)
8. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M,. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26: 1255-1261. (Pubitemid 41435454)
9. Lavi S, Kapeliovich M, Gruberg L, Roguin A, Boulos M, Grenadier E, Amikam S, Markiewicz W, Beyar R, Hammerman H,. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: Impact on long-term prognosis. Int J Cardiol 2008; 123: 117-122. (Pubitemid 350250888)
10. Abbate A, Biondi-Zoccai GG,. The difficult task of glycaemic control in diabetics with acute coronary syndromes: Finding the way to normoglycaemia avoiding both hyper- and hypoglycaemia. Eur Heart J 2005; 26: 1245-1248. (Pubitemid 41435451)
11. Ceriello A,. Acute hyperglycaemia: A 'new' risk factor during myocardial infarction. Eur Heart J 2005; 26: 328-331. (Pubitemid 40283091)
12. Wright RJ, Frier BM,. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008; 24: 353-363.
13. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33 (Suppl 1): S62-S69.
14. Alpert JS, Thygesen K, Antman E, Bassand JP,. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
15. Thygesen K, Alpert JS, White HD,; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634-2653. (Pubitemid 350182388)
16. Frier BM, Corrall RJ, Davidson NM, Webber RG, Dewar A, French EB,. Peripheral blood cell changes in response to acute hypoglycaemia in man. Eur J Clin Invest 1983; 13: 33-39. (Pubitemid 13184597)
17. Collier A, Patrick AW, Hepburn DA, Bell D, Jackson M, Dawes J, Frier BM,. Leucocyte mobilization and release of neutrophil elastase following acute insulin-induced hypoglycaemia in normal humans. Diabet Med 1990; 7: 506-509. (Pubitemid 20199795)
18. Ibbotson SH, Catto A, Davies JA, Grant PJ,. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin-dependent) diabetes. Thromb Haemost 1995; 73: 243-246.
19. Wright RJ, Macleod KM, Perros P, Johnston N, Webb DJ, Frier BM,. Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2007; 24: 1039-1042. (Pubitemid 47301640)
20. Galloway PJ, Thomson GA, Fisher BM, Semple CG,. Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care 2000; 23: 861-862. (Pubitemid 30414210)
21. Trovati M, Anfossi G, Cavalot F, Vitali S, Massucco P, Mularoni E, Schinco P, Tamponi G, Emanuelli G,. Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes 1986; 35: 818-825. (Pubitemid 16035666)
22. Stanley WC, Recchia FA, Lopaschuk GD,. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093-1129. (Pubitemid 40894649)
23. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van 't Hof AW,; Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45: 999-1002. (Pubitemid 40432429)
24. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D,. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072. (Pubitemid 35192812)
25. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E,. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995; 44: 924-928.
26. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, Lalli C, Ciabattoni G, Davì G, Bolli GB,. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013-1020. (Pubitemid 36315547)
27. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P,. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973. (Pubitemid 32269184)
28. Nakamura N, Ueno Y, Tsuchiyama Y, Koike Y, Gohda M, Satani O,. Isolated post-challenge hyperglycemia in patients with normal fasting glucose concentration exaggerates neointimal hyperplasia after coronary stent implantation. Circ J 2003; 67: 61-67. (Pubitemid 36119623)
29. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, Origgi A, Zavaroni I, Margonato A, Colombo A,. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074-2081. (Pubitemid 37337582)
30. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW,. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004; 43: 8-14. (Pubitemid 38045906)
31. Lindsay J, Sharma AK, Canos D, Nandalur M, Pinnow E, Apple S, Ruotolo G, Wijetunga M, Waksman R,. Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C. Cardiovasc Revasc Med 2007; 8: 15-20. (Pubitemid 46216178)
32. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE,. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 8150-8154.
33. Lindner V, Reidy MA,. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743. (Pubitemid 21916699)
34. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, Peters A,. Vascular endothelial growth factor: A novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 2002; 87: 835-840. (Pubitemid 34158260)
35. Gaspardone A, Versaci F,. Coronary stenting and inflammation. Am J Cardiol A 2005; 96: 65L-70L.
36. Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A,. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. Am J Cardiol 2002; 89: 372-376. (Pubitemid 34142508)